Land: New Zealand
Språk: engelsk
Kilde: Medsafe (Medicines Safety Authority)
Sucralfate 1 g equivalent to to 190 mg aluminium;
Viatris Limited
Sucralfate 1 g (Equiv. to 190 mg aluminium)
1 g
Tablet
Active: Sucralfate 1 g equivalent to to 190 mg aluminium Excipient: Carmellose sodium Macrogol 1500 Magnesium stearate Microcrystalline cellulose Water
Bottle, plastic, HDPE, 1x120, 120 tablets
General sale
General sale
Fuji Chemical Industries Co. Ltd.
Treatment of acute, non-malignant gastric ulcer and duodenal ulcer. Maintenance therapy to prevent the recurrence of duodenal ulcers.
Package - Contents - Shelf Life: Bottle, plastic, HDPE, 1x120 - 120 tablets - 24 months from date of manufacture stored at or below 30°C
1983-04-28
Page 1 of 3 NEW ZEALAND CONSUMER MEDICINE INFORMATION CARAFATE _SUCRALFATE, TABLET 1G _ WHAT IS IN THIS LEAFLET Please read this leaflet carefully before you start taking CARAFATE. This leaflet answers some common questions about CARAFATE. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor or pharmacist has weighed the risks of you taking CARAFATE. against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT CARAFATE IS TAKEN FOR CARAFATE is taken to treat and prevent duodenal and gastric ulcers_._ CARAFATE contains the active ingredient sucralfate. It belongs to a group of medicines used to treat ulcers and gastro-oesophageal reflux disease. It works in the stomach by producing a substance that sticks to the ulcer site that protects it from the damaging action of enzymes and stomach acid which can cause ulcers CARAFATE is not an antacid. Your doctor or pharmacist may have recommended this medicine for another reason. ASK YOUR DOCTOR OR PHARMACISTS IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN RECOMMENDED FOR YOU. This medicine is available from your pharmacy without a prescription. This medicine is not addictive. BEFORE YOU TAKE CARAFATE _WHEN YOU MUST NOT TAKE IT_ DO NOT TAKE CARAFATE IF YOU HAVE AN ALLERGY TO: any medicine containing sucralfate any of the ingredients listed at the end of this leaflet. Some of the symptoms of an allergic reaction may include: shortness of breath; wheezing or difficulty breathing; swelling of the face, lips, tongue or other parts of the body; rash, itching or hives on the skin. DO NOT GIVE THIS MEDICINE TO A CHILD UNDER THE AGE OF 18 YEARS. Safety and effectiveness in children younger than 18 years have not been established. DO NOT TAKE THIS MEDICINE IF YOU are on dialysis have a bleed read_full_document
Page 1 of 5 NEW ZEALAND DATA SHEET CARAFATE 1. PRODUCT NAME Carafate, 1 g, tablet. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 1 g sucralfate For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Carafate is a white, uncoated capsule-shaped tablet. One side is plain, the other embossed with the word ‘CARAFATE’. Dimensions: 20 mm x 9 mm x 7mm 4. CLINICAL PARTICULARS _4.1 _ _THERAPEUTIC INDICATIONS_ Treatment of acute, non-malignant gastric ulcer and duodenal ulcer. Maintenance therapy to prevent the recurrence of duodenal ulcers. _4.2_ _DOSE AND METHOD OF ADMINISTRATION_ ACUTE ULCEROUS CONDITIONS The recommended adult dose of Carafate for duodenal ulcer and gastric ulcer is 1 g tablet three times a day, one hour before meals and one 1 g tablet at bedtime or two 1 g tablets twice daily taken before breakfast and at bedtime (for up to 8 weeks). For relief of pain, antacids may be added to the treatment. However, they should not be taken within two hours before or after sucralfate intake. In duodenal ulcer, while healing with sucralfate often occurs within two to four weeks, treatment should be continued for up to 8 weeks unless healing has been demonstrated by x-ray and/or endoscopic examination. In the case of gastric ulcers an alternative treatment should be considered if no objective improvement is observed following 6 weeks of sucralfate therapy. Large gastric ulcers that show a progressive healing tendency may require the full 8 weeks of therapy. MAINTENANCE TREATMENT To reduce the risk of recurrence of duodenal ulcers, the recommended dose is one 1 g tablet before breakfast and one at bedtime (for up to 12 months). When necessary for relief of pain, antacids may be added to the treatment. However, they should not be taken within two hours before or after taking sucralfate. Page 2 of 5 _4.3_ _CONTRAINDICATIONS_ Carafate is contraindicated in patients on dialysis as long term administration may cause symptoms such as aluminium encephalopathy, aluminium osteomalacia and read_full_document